The naïve pluripotent state has been shown in mice to lead to broad and more robust developmental potential relative to primed mouse epiblast cells. The human naïve ES cell state has eluded derivation without the use of transgenes, and forced expression of OCT4, KLF4, and KLF2 allows maintenance of human cells in a naïve state [Hanna J, et al. (2010) Proc Natl Acad Sci USA 107 (20):9222-9227]. We describe two routes to generate nontransgenic naïve human ES cells (hESCs). The first is by reverse toggling of preexisting primed hESC lines by preculture in the histone deacetylase inhibitors butyrate and suberoylanilide hydroxamic acid, followed by culture in MEK/ERK and GSK3 inhibitors (2i) with FGF2. The second route is by direct derivation from a human embryo in 2i with FGF2. We show that human naïve cells meet mouse criteria for the naïve state by growth characteristics, antibody labeling profile, gene expression, X-inactivation profile, mitochondrial morphology, microRNA profile and development in the context of teratomas. hESCs can exist in a naïve state without the need for transgenes. Direct derivation is an elusive, but attainable, process, leading to cells at the earliest stage of in vitro pluripotency described for humans. Reverse toggling of primed cells to naïve is efficient and reproducible.
The naïve pluripotent state has been shown in mice to lead to broad and more robust developmental potential relative to primed mouse epiblast cells. The human naïve ES cell state has eluded derivation without the use of transgenes, and forced expression of OCT4, KLF4, and KLF2 allows maintenance of human cells in a naïve state [Hanna J, et al. (2010) Proc Natl Acad Sci USA 107 (20) :9222-9227]. We describe two routes to generate nontransgenic naïve human ES cells (hESCs). The first is by reverse toggling of preexisting primed hESC lines by preculture in the histone deacetylase inhibitors butyrate and suberoylanilide hydroxamic acid, followed by culture in MEK/ERK and GSK3 inhibitors (2i) with FGF2. The second route is by direct derivation from a human embryo in 2i with FGF2. We show that human naïve cells meet mouse criteria for the naïve state by growth characteristics, antibody labeling profile, gene expression, X-inactivation profile, mitochondrial morphology, microRNA profile and development in the context of teratomas. hESCs can exist in a naïve state without the need for transgenes. Direct derivation is an elusive, but attainable, process, leading to cells at the earliest stage of in vitro pluripotency described for humans. Reverse toggling of primed cells to naïve is efficient and reproducible. I t has become clear with the derivation of mouse epiblast stem cells (mEpiSCs) that pluripotency encompasses more than one stage of development (1, 2) . The earlier "naïve" stage represents the preimplantation inner cell mass, typified by mouse ES cells (mESCs), and the "primed," the postimplantation epiblast, typified by mEpiSCs and human ES cells (hESCs). The challenge in naïve cell maintenance has been protecting cells from differentiation stimuli. This has been achieved in mESCs through exposure to leukemia inhibitory factor (LIF), whereas addition of extracellular signal-regulated kinase (MEK) and glycogen synthase kinase 3 (GSK3) inhibitors (2i) in defined medium allows the cells to attain a homogeneous ground state (3) . Defining characteristics of the naïve/ground vs. primed states are shown in Fig. S1A . In humans, the naïve stage has been difficult to capture as a stable in vitro state.
There are practical advantages that come with a human naïve state. Among them is ease of trypsin passage and developmental capacity. Whole animals can be generated from good naïve mESCs through tetraploid complementation (4) , and mEpiSCs cannot contribute to chimerism. Being more comparable to mESCs, naïve hESCs will likely allow increased developmental potential and a more accurate correlation to mESC data.
It has been reported that human induced pluripotent cells (h-iPSCs) can be maintained in the naïve state if the pluripotency-inducing transgenes are not silenced (5) . Only recently have hESCs been maintained in a naïve state without transgenes (6) . Our primary aim was to generate naïve hESCs not dependent upon transgenes for stable culture. We toggled existing human ESC and mouse mEpiSC lines back from the primed state to grow under the influence of 2i without the need for Activin A. This helped us to define appropriate culture conditions for human naïve cells and allowed the de novo derivation of a naïve hESC line, Elf1. We report on the naïve state of human ESCs capable of unlimited culture in 2i.
Results
Primed Mouse and Human Pluripotent Cells Acclimate to Naïve 2i
Culture. In an earlier report, we described toggling mouse and human ESCs to an earlier state using a histone deacetylase inhibitor (HDACi) (7) . Thus, we used this approach as a stepping stone to reverse primed cells to a naïve state. mEpiSCs and hESCs were converted to 2i culture following one to three passages in a mixture of HDACi consisting of sodium butyrate and suberoylanilide hydroxamic acid (SAHA, vorinostat) (B/S); nomenclature is explained in Methods). Without preexposure to B/S, the majority of the primed stage mouse and human cells differentiated following exposure to 2i ( Fig. 1 A and B and Fig.  S1 B-G), as expected (3). Once cells were passaged through B/S, both mouse and human responded to 2i through formation of tight colony edges reflective of mESCs ( Fig. 1B and Fig. S1B ). These human cultures remained dependent on basic fibroblast growth factor (FGF2; F). All stages of pluripotency reflected under these culture conditions express POU class 5 homeobox 1 (OCT4), Nanog homeobox (NANOG), and the cell surface proteins TRA-1-60 and TRA-1-81. Unlike naïve mESCs, both naïve and primed hESCs are stage-specific embryonic antigen-4 (SSEA4)-positive while remaining SSEA1-negative (Fig. S2A) . Primed H1, intermediate H1 (in B/S), and naïve H1 (in 2iF)
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We report on generation of nontransgenic, naïve human pluripotent cells that represent the developmentally earliest state described for human established cells. Existing human ES cell lines in the later primed state can be toggled in reverse to naïve by exposure to histone deacetylase inhibitors prior to naïve culture. A new line was established directly from an eight-cell embryo under naïve culture conditions. We describe the naïve state in humans and show that naïve human ES cells have expanded endoderm developmental capacity. Data deposition: The Agilent array data reported in this paper has been deposited in the Synapse Commons Repository database, https://synapse.sagebase.org/ [accession nos. syn1447097 (H1-2iF vs. H1), syn1447098 (Elf1-3iL vs. Elf1-AF), and syn1447101 (mESC vs. mEpiSC vs. mEpiSC-2iL)]. 1 To whom correspondence should be addressed. E-mail: cware@u.washington.edu. To explore the biological effect of LIF, naïve H1s were exposed to human LIF or FGF2. Cells that were supported on feeders with LIF exhibited a naïve mESC-like morphology by mounding, whereas colonies were flatter in FGF2 (Fig. S1 C-F) . Despite the naïve mESC morphology following one passage, H1-2iL began showing signs of differentiation by the third passage and were lost to differentiation by the third to fifth passage (Fig. S1G) .
Along with five hESC lines (H1, H7, H9, HUES1, and HUES2), two mEpiSC lines (mEpiSC5 and mEpiSC7, 2) and two human induced pluripotent lines were converted to 2i culture. In addition, one nonhuman primate line (MF-1; Macaca fascicularis; a gift of Eliza Curnow, Washington National Primate Research Center, Seattle) was converted to 2i culture (Fig. S1H ). Unlike hESCs, the nonhuman primate line could survive over several passages in LIF with no FGF2 and did not require HDACi to reverse toggle, indicating a species difference between humans and M. fascicularis.
Gene Expression of H1 Cultured As Naïve Indicates an Earlier Pattern.
We analyzed the differences between the stages of human pluripotency, primed and toggled naïve through Agilent whole human genome array comparisons. Hypoxia inducible factor 2α (HIF2α) (EPAS1) seems to be diagnostic of the 2iF stage in that a significant number of HIF2α targets show a unique expression pattern in naïve H1 cultures relative to primed ( Fig. 2A; hypergeometric distribution, P < 0.01).
To determine whether cells that were toggled through B/S to 2i could be defined as "naïve" we used principal component analysis. Microarray expression data derived from the mEpiSCs, mEpiSCs converted to 2iL, and mESCs were compared with a mouse developmental yardstick (8) (GSE8881), in which inner cell mass (icm) was collected from mouse embryos at preimplantation (E3.7; thought to be equivalent to naïve mESC), delayed implantation icm of diapause (E7.5, i.e., 3-d delay), and postimplantation epiblast (E6.5). Clustering within a quadrant would represent altered states as determined by expression. The difference between right and left quadrants would be more profound than the difference between top and bottom. Although the toggled naïve mESCs [mEpiSC-(B/S)2iL] have the morphological appearance of mESCs (Fig. S1B ), these cells are more similar to delayed-implantation icm (Fig. 2B) . Thus, there is likely an advantage to direct naïve cell derivation. Therefore, we generated a new hESC line from a donated embryo under the naïve culture conditions determined by H1-2iF cells.
Generation of a New Naïve hESC Line. One eight-cell embryo formed what seemed to be a naïve hESC line, with mounded colony morphology having bright edges (Fig. S1I) . The efficiency (8) embryo data (Left) to mESC equivalents: R1p22 (mESC-2iL, naïve), mEpiSC7p24AF (mEpiSC-AF, primed), and mEpiSC7p55 (AF7,B/S1)2iL20 (mEpiSC-2iL, toggled to naïve) (Right). Elf1 naïve (3iL, green squares) and primed (AF, blue squares) expression data are compared with the in vivo mouse embryo data in the plot on the left. (C) Comparison of inhouse Elf1 expression array data as the standard against which to measure in-house (UW) data (H1-2iF × four repetitions; primed: H1 × four repetitions) and that generated by Hanna et al. (5) . Naïve: C1.1, C1.2, WIBR3.1, WIBR3.3, WIBR3.5; primed: first grouping-BG01, BG01-mTeSR; BG01-NANOGtgk; second grouping-WIBR1, WIBR2, WIBR3rep1, WIBR3rep2, and WIBR3-5%O 2 . Note that the lines tested on left side that are compared with naïve Elf1 are grouped identically on the Elf1 primed side of the graph. Presumed naïve cell lines are represented by dark blue dots and presumed primed are orange. (D) DNase I hypersensitivity analysis of the POU5F1 enhancer regions for Elf1 (lower line black) and H1 (line above in blue). The first exon of POU5F1 is shown above the H1 data along with a 2-kb size bar to map the proximal enhancer (PE) and distal enhancer (DE). (E) ChIP-seq H3K27me3 comparison of primed hESCs [orange line, data taken from Gafni et al. (6) ] to naïve Elf1-2iL (blue line) using the genes in C that intersect with Gene Ontogeny "developmental genes" (n = 648).
of establishing a human pluripotent line in 2i was quite low at one line from 128 donated embryos, primarily frozen as blastocysts. Elf1 is positive for OCT4, NANOG, TRA-1-60, TRA-1-81, and SSEA4 while remaining negative for SSEA1 (Fig. S2A) , consistent with recent reports (5, 6). The line was karyotyped at passage 9 and found to be a normal female (Fig. S2B) .
Although Elf1 was started in 2iF, we attempted to convert it to 3i (includes an FGF receptor inhibitor) + human LIF, to determine whether Elf1 could grow independently of FGF2. Elf1-3iL resulted in a more mounded morphology characteristic of mESC (Fig. S1I) . Unlike H1-2iF, Elf1-3iL could be stabilized without FGF2. Elf1 could be maintained as naïve indefinitely in 3iL and 2iL and as such has been grown stably for more than 60 passages. However, when FGF is not present there is an increased background of differentiated cells. There was negligible culture drift when maintained in 2iF.
Two questions concerning culture arose. What is the operative signaling mechanism of FGF2 in the presence of an MEK inhibitor? Mammalian target of rapamycin (mTOR) survival signaling is a possible alternative pathway used by FGF2. Both naïve and primed Elf1 were sensitive to mTOR inhibition through exposure to rapamycin (Fig. S3A) . The second question concerns the role of the Janus kinase/signal transducers and activators of transcription (JAK/STAT) pathway in naïve Elf1 cells. A STAT3 inhibitor (NSC74859) was added to the 2iL medium, which caused naïve cells to slow growth, whereas Elf1s induced to the primed stage through Activin and FGF (AF) were not obviously affected (Fig. S3B ).
Elf1 Gene Expression Indicates the Line Is Naïve. Using the Sage resources, Agilent expression data were compared with archived array data. A set of 628 naïve Elf1 specific enriched (fourfold or greater) genes and of 639 primed Elf1 specific enriched genes were used as a yardstick against which to compare our data with that in the literature. Naïve Elf1 expression, but not primed Elf1, was found to correlate with previously reported naïve h-iPSC expression using persistent expression of transgenes (5) (Fig.  2C) . All of the primed hESC lines showed an expression signature that was clearly different from the naïve signature. Furthermore, cell lines treated as primed showed the most variability in expression pattern. This could partially explain some of the biological variability seen among primed hESCs.
The Elf1 array data were compared with the same previously generated mouse embryo data used in Fig. 2B . The naïve Elf1 cells did fall into the same quadrant with mouse peri-implantation icm as seen in delayed implantation embryo analysis whereas primed Elf1s reflected mEpiSCs (Fig. 2B) . This is remarkable given the diversity of expression between mice and humans and the differences in experimental process, indicating that Elf1s are within the mouse naïve definition by expression. Curiously, primed Elf1 cells could be switched back to naïve conditions (2iL) without the need for a B/S intermediate step, indicating a fundamental difference between hESCs derived under naïve conditions, but cultured as primed, and hESCs generated initially as primed cells.
MicroRNA (miR) pattern change is implicated during initiation of development. For this reason, we decided to look at select miRs, miR-302b, miR-372, miR-518b, miR-520b, and miR520c. These miRs are expressed in the primed state of human pluripotency (9, 10) . miR-302b is thought to remain relatively stable throughout human pluripotency and was used as a positive control for the pluripotent state. miR-372 may increase in hESC developmentally earlier than primed (10, 11) . As part of a primate-specific chromosome 19 miR cluster (CM19C), miR-518b, miR-520b, and mir-520c are known to be expressed in the primed state and to decline upon differentiation (9) . Thus, an increase in these miR levels relative to miR 302b would indicate that the cells are earlier in pluripotent development. miR-302b did remain reasonably stable in naïve and primed hESCs (Elf1, H1, and H7), as expected. Expression of miRs 518b and 520b and 520c increased in the naïve state relative to primed while miR-372 expression increased in Elf1 relative to H1 and H7 (Fig. 3A) .
To compare our ELF1 data to a recent report (6) on naïve hESCs we looked at two parameters, POU5F1 (OCT4) enhancer use and presence of H3K27me3. Naïve cells depend upon the distal OCT4 enhancer, whereas primed cells use the proximal enhancer (5, 6). We detected a similar phenomenon using DNase I hypersensitivity analysis, which is useful for pinpointing poised and active regulatory regions. Increased hypersensitivity mapped to the distal enhancer in Elf1 and to the proximal enhancer in H1 (Fig. 2D) . Recently, naïve hESCs were shown to exhibit reduced H3K27me3 at developmental gene promoters (6) . We generated H3K27me3 ChIP-seq data in Elf1 naïve conditions and compared this to published H3K27me3 hESC-primed levels (6) at 648 developmental genes used for comparison in Fig.  2C . We see an overall reduction of H3K27me3 signal in naïve cells (P < 2.2 × 10
), in agreement with previous findings. within the nucleus. When the nucleus is highlighted using DAPI and the field magnified XIST remains undetectable in naïve Elf1 (Lower Left), whereas the XIST signal can be detected upon differentiation on one or both X chromosomes (red dots, white arrows, Lower Right two panels). (C) Bisulfite sequencing of the XIST promoter using the 11L-11R primers shows that XIST remains methylated throughout the naïve and primed stages. Using the 7L-7R primers, methylation seems to diminish in naïve relative to primed cells, 10-d in vitro-differentiated cells and in the 98-d teratoma. Note that the 1, 9, and 11 primer sets did not vary from data shown for set 11 upon differentiation. Open circles indicate unmethylated and filled circles indicate methylated CpGs. (D) Graphs representing cloning efficiency (percent) and doubling times (hours) of Elf1 naive (green), Elf1 primed (yellow), H1 naïve (dark blue), and H1 primed (light blue). (E) Electron microscopy of mitochondria. The left panels show the mitochondrial shape difference between Elf1-3iL and Elf1-AF. This is quantified in the graph on the right, where increased ratio indicates a rounder mitochondrial population (± SEM). ***P < 0.001, **P < 0.01, and *P < 0.05 as determined by t test.
Elf1 Cells
explore X inactivation. FISH analysis for X-inactive specific transcript (XIST) indicated the absence of a signal in naïve Elf1. Two XIST clouds arose in primed cells, and two clouds were present in some of the cells upon random differentiation for 10 d in FBS, but there were also cells with only one cloud (Fig. 3B) . Identification of both Xs via XIST-FISH before X inactivation is consistent with a previous observation on human embryos (12) . Thus, we looked at XIST promoter methylation as an indicator of an inactive X, using four primer sets (13) . Sets 1L-1R, 9F-9R, and 11F-11R indicated similar extensive promoter methylation in the naïve, primed, and differentiated states. The promoter region detected by the 7L-7R set indicated demethylation of XIST in naïve cells relative to primed and differentiated states. Absence of X inactivation may, in part, be a feature of low oxygen culture, as previously described (13) .
Naïve hESCs Double More Rapidly and Clone More Efficiently Than
Primed hESCs. We measured both cloning efficiency and population doubling time in Elf1 naïve (2iL), Elf1 primed (AF), H1 naïve (2iF), and H1 primed (Fig. 3D ). Elf1 naïve cloning efficiency was twice that of the other lines, and doubling time was halved relative to H1. Elf1 primed and H1 naïve characteristics are intermediate. The trend seen is similar to that reported (5, 6), although absolute numbers are not identical, likely owing to technical differences in the assays.
Mitochondrial Metabolism As a Functional Marker of Pluripotency
Stage. mESCs are bivalent and can convert between mitochondrial and glycolytic metabolism depending on culture conditions, whereas mEpiSCs and hESCs are dependent primarily on aerobic glycolysis (14) . Consistent with the mouse data, expression of cytochrome c oxidase assembly protein and estrogen receptorrelated receptor B were significantly higher in the naïve Elf1 cultures relative to primed Elf1 (P < 1 × 10 −4 and P < 0.01, respectively; Agilent array data), signifying effective mitochondrial oxidative metabolism. Primed Elf1 increased RNA expression of HIF1α targets lactate dehydrogenase A, phosphoinositidedependent kinase-1 (PDK1), and phosphorylase, glycogen, liver (PYGL) (P < 10 −5 , P < 0.01, and P < 0.01, respectively). HIF1α is known to play an instrumental role in support of aerobic glycolysis. The dependence of the primed state on glycolysis likely confers a growth advantage that may be correlated to that seen in cancer cells through the Warburg effect. PDK1, 2, and 3 are all up-regulated in primed Elf1 cells (P < 0.01, P < 0.01, and P < 10 , respectively), indicating that some of the mechanism of primed cell mitochondrial shutdown may be similar to that seen in the Warburg effect (15, 16) .
Mitochondrial morphology was assessed in naïve Elf1 and primed Elf1 by electron microscopy. Reflective of the mouse naïve vs. primed cells (14) , naïve Elf1 mitochondria appeared less mature, in that they were generally round with few cristae, whereas mitochondria in primed cells were elongated with somewhat more developed cristae (Fig. 3E) .
Teratoma Formation. Teratoma formation has conventionally been used in pluripotent cell assessment to determine the ability of a line to generate the three germ lineages. Representatives of the three germ lineages are present in teratomas from toggled and de novo-derived naïve hESCs, proving their pluripotency (Fig. 4) . This assay has the potential to highlight the lineage differentiation potential of any individual pluripotent line. It is in this regard that we pursued teratoma formation to determine the endoderm lineage contribution.
Tumors were harvested from animals injected with naïve Elf1 cells within 42-50 d and primed Elf1 by 67 d, when they were first detectable by palpation. Studies by others with primed hESC-generated teratomas have noted the disproportionate amount of mesoderm in the tumor mass (amounting to between two-thirds and three-fourths of the tumor) (17, 18) . As shown in Fig. 4B , teratomas derived from both naïve and primed Elf1s contained significant compartments occupied by E-cadherinpositive areas whose phenotype could be clearly ascribed to definitive endoderm cell lineages owing to the proximity to the developing liver. Specific examples are shown for the liver cell lineage, marked by the expression of albumin, α-fetoprotein, and cytochrome P450, family 3, subfamily A (CYP3A), whereas in adjacent sections pancreatic cell lineage marked by the expression of pancreatic and duodenal homeobox 1 (PDX1) and SOX9 in E-cadherin-positive cells seems associated with, yet separate from, liver development. Immunoreactivity for hepatocyte nuclear factor 4, alpha (HNF4A), CYP3A, forkhead box A2 (FOXA2), and/or sex determining region Y, box 9 (SOX9) also identifies regions occupied by more immature common progenitors for liver and pancreas lineages. This phenotype contrasts with that observed in teratomas derived from primed H1 cells, in which clusters of immature endoderm were reduced relative to naïve H1. E-cadherin immunoreactivity, indicating epithelial cells and PDX1 immunoreactivity, indicating pancreas progenitors, were both increased in the naïve H1 (Fig. 4C, graph) . Reversion of naïve cells to primed via culture reduces both E-cadherin-and PDX1-positive areas. Lineage marker data were combined for H1 and Elf1 naïve (n = 6) vs. primed (n = 4) teratomas (Fig. S4) . Endoderm was increased in the naïve cellgenerated tumors explored relative to the two primed cell-generated tumors, whereas neural and mesenchymal lineages were reduced.
Because mESCs are the naïve gold standard, we assessed mESC teratomas. These were harvested 13 d following injection. mESC-generated tumors looked similar to hESC-generated tumors. Endoderm was well developed (Fig. 4D) , although immature, relative to day-42 to day-67 naïve human teratomas. Overall, the teratoma data indicate that robust endoderm development is attenuated when hESCs are derived under primed conditions. Lineage potential seems to be protected throughout in vitro pluripotent culture if hESCs are derived as naïve. Robust lineage potential is regained when H1s are toggled backward through HDACi to a naïve state.
Discussion
We show that naïve human pluripotent cells can be derived directly from the preimplantation human embryo and that hESCs derived beyond a point in the transition from naïve to primed maintain the ability to become stably naïve in response to culture conditions. This is supported by a recent report (6) that, in addition to 2iLF, used increased MAP kinase pathway inhibition through p38 and JNK inhibition along with transforming growth factor beta (TGF-β) addition to allow reverse toggling and maintenance of de novo-derived naïve hESCs. In our hands, reverse toggling of primed hESCs is facilitated by HDACi exposure in humans, whereas in mice naïve cells can arise directly from mEpiSC cultures under naïve conditions (19) . However, we see that preculture in HDACi assists mEpiSCs in surviving initial exposure to 2i.
The ability to maintain reverse-toggled hESCs in a naïve state seems to hinge around the continued presence of FGF. Human response to FGF2 does not completely phenocopy the mouse during the naïve-to-primed transition. Unlike in mice, human hypoblast formation does not require FGF2 (20) , whereas FGF2 response in the presence of MEK/ERK inhibitor indicates that FGF is likely to have a positive effect on self-renewal in both the naïve and primed states, although perhaps through different signaling pathways. Active MEK signaling is important in the primed state, whereas phosphoinositide 3-kinase/mTOR signaling or another FGF-induced cell signal suppresses differentiation in both the naïve and primed states. In support of this, mouse primordial germ cells require a 1-d exposure to FGF2 to toggle to pluripotency, and forskolin can substitute for FGF2 in this context (21) . Because human iPSCs can survive as naïve if cultured continuously in forskolin (5), this suggests that forskolin can, at least partially, substitute for continuous presence of FGF2 to stabilize hESC in the naïve state. We have been unable to generate a new hESC line directly in 2iL, and the one line generated in 2iF was thawed as an eight-cell embryo. The presence of FGF2 and/or the stage of development at freeze/thaw may have been crucial to halting development in the naïve state. The extremely poor direct derivation rate of naïve hESCs from embryos may be due to culture conditions marginal with regard to halting human icm development. Increased inhibition of MAP kinase signaling, in addition to MEK inhibition through the use of p38 and JNK inhibitors (6), may improve naïve hESC derivation rate. We note that the amount of GSK3i used influenced culture stability such that cells selfrenewed in 0-2 μM GSK3i, whereas 5 μM drove differentiation. This varies from mESCs, where 3 μM GSK3i is optimal (3), but is similar to observations made with naïve rat ESCs, for which 1 μM GSK3i is optimal (22, 23) . Excess GSK3i may enable Wnt-induced nuclear events that are counter to the naïve state.
A key advantage of naïve hESCs is the predicted ability to better reflect development. This expectation has been borne out in the teratoma assays. Generation of the endoderm lineage is particularly robust from naïve cells. We interpret this to mean that some tissue restriction for teratoma formation occurs when hESCs are established in the primed state. A caveat to claiming that teratoma developmental potential reflects fetal development arises out of a recent paper (24) showing that mouse cells derived as primed mEpiSCs can integrate correctly into fetal tissue if introduced into epiblast stage embryos. However, given the nature of the postimplantation epiblast chimera assay that disallows reinitiation of pregnancy to term, it is difficult to assess the difference between the lineage contribution. Changes to teratoma tissue contribution do not necessarily reflect true embryonic developmental potential, but it is the best assay we currently have for human pluripotent cells.
LIF-related receptor function is active in the naïve state, as determined by array analysis and STAT3 inhibition. Thus, upregulation of LIFR and gp130 in the context of stem cell morphology is likely a good indicator of the naïve state in the absence of other markers. The presence of miR-302b indicates pluripotency, whereas an increase in miR-518b, miR-520b, and miR-520c indicates a move to an earlier pluripotency stage. Mitochondrial morphology is also a good indicator of a naïve line. Once an appropriate morphology is detected, a few relatively inexpensive tests of mitochondrial morphology and gene expression can detect the naïve state. Elf1 cells can be used to develop an in vitro differentiation assay to detect the extent of endoderm development as a naïve hallmark, and the naïve parameters above serve as indirect evidence of developmental potential.
In summary, a stable, naïve hESC state does exist without the need for transgenes and can be maintained indefinitely through trypsin passage. The cells seem karyotypically stable with hallmarks consistent with a mouse naïve state, including gene expression, teratoma formation, and immature mitochondrial and overall morphology. Naïve hESCs are capable of robust differentiation to all three germ lineages, with a heightened capability of endoderm formation not previously seen in hESCs.
Methods
Oversight. Animals. All procedures with mice followed the recommendations and approval of the Institutional Animal Care and Use Committee of the University of Washington and were performed within an American Association for the Advancement of Laboratory Animal Care-accredited specific pathogen-free facility at the University of Washington. Human subjects. Approval was received from the University of Washington Institutional Review Board to obtain consent for donation of excess cryopreserved human embryos from fertility clinic patients to generate new human ESC lines. All embryo donations followed informed consent. Embryonic stem cell research oversight. All embryonic stem cell work was preapproved by the University of Washington Embryonic Stem Cell Research Oversight Committee.
Cell Line Nomenclature. For example, H1p52(B/S3)2iF10 indicates H1 cultured for a total of 52 passages. Cells were exposed to butyrate + SAHA for three passages from p40-p42 and then to 2i + FGF for 10 passages from p43 to p52.
Culture of Pluripotent Cells. Initial cultures of hESC [H1 (NIH code WA01), H7 (NIH code WA07), H9 (NIH code WA09), BG02, and HUES2], nonhuman primate M. fascicularis (MF-1), mEpiSC5, and mEpiSC7 ES cells were grown on a feeder layer of gamma-irradiated (3,000 Rad) primary mouse embryonic fibroblasts (MEFs) (7, 25) . For cultures without feeders, cells were plated on Matrigel (BD Biosciences) diluted according to the manufacturer's instructions. Cultures were incubated at 37°C in 5% C0 2 , 5% O 2 , and 90% N 2 . hESC culture medium consisted of high-glucose DMEM/F12 containing GlutaMax supplemented with 20% KnockOut serum replacer (SR), 1 mM sodium pyruvate, 0.1 mM nonessential amino acids, 50 U/mL penicillin, 50 mg/mL streptomycin (all from Invitrogen), and 0.1 mM β-mercaptoethanol (SigmaAldrich). To reverse toggle, hESCs were first cultured in the presence of an HDACi mixture containing 0.1 mM sodium butyrate (Sigma-Aldrich) plus 50 nM SAHA (B/S; Cayman). Human LIF was used when LIF is specified for human and nonhuman primate ESCs. Factors were used at the following concentrations: 10 ng/mL hLIF (Chemicon), 10 ng/mL Activin A (Humanzyme), 10 ng/mL FGF2 (Invitrogen), 0.4-0.8 μM PD0325901 (Selleck), 1.0-3.0 μM CHIR99021 (Selleck), 2 μM SU5402 (Calbiochem), 0.1 μM NSC74859 (Selleck), and 10 μM Y-27632 (Selleck). Primed cells and human cells in B/S were exposed to 1.2 U/mL dispase (Invitrogen) dissolved in PBS supplemented with SR. Naïve cells and mouse cells in B/S were passaged using trypsin/EDTA (Invitrogen).
mESCs were cultured in either DMEM or DMEM/F12 with the additives described above, except the serum replacer was substituted with 20% FBS (ES qualified; Invitrogen), unless otherwise stated. MEF-free cultures were grown on Matrigel-coated dishes using medium supplemented as indicated in the text. Mouse LIF was used at 1,000 units/mL for mESCs (ESGRO; Chemicon).
Cells for undirected differentiation were seeded at ∼2 × 10 5 cells per uncoated, gelatinized, or Matrigel-treated 10-cm plate in DMEM (Invitrogen) containing 20% FBS (ES cell tested; Invitrogen) with penicillin and streptomycin (Invitrogen). Cells were allowed to attach and fluid was changed every other day.
Establishment of Elf1. Elf1 was thawed as a six-to eight-cell embryo, cultured to expanded blastocyst in blastocyst medium (Sage), and kept in a 5% CO 2 , 5% O 2 atmosphere throughout. Four days after thaw, the zona pellucida was removed using Acidified Tyrode's Solution and the zona-free embryo plated into one well of a 96-well plate seeded with feeders. The first passage was mechanical 3 d following the removal of the zona. Seven days later, passage was through mechanical plucking of a growth above the plated colony. Subsequent passages used Trypsin/EDTA. The culture seemed established by passage 5. Henceforth, the cells were passaged two times per week using trypsin/EDTA. Elf1 was bulk-frozen at passage 8 in hESC culture medium plus 10-12 ng/mL FGF2, 3 μM CHIR 99021, and 0.4 μM PD0329501 (2iF) using the cryoprotectant dimethylsufloxide (10%; Sigma) and given the name Elf1, "El" to honor the Ellisons, who donated the funds for the work, and "f1" for female, line one. Elf1 is on the NIH Stem Cell Registry (0156; approved May 15, 2012) and is being banked at WiCell for distribution.
Microarray Analysis. Whole mouse and whole human genome arrays (Agilent) were hybridized with total RNA from ESCs cultured with additives as indicated in the text. These were run in independent quadruplicate through the array facility at Seattle Biomedical Research Institute.
Microarray Data Preprocessing. The data for each experiment were stored as raw, preprocessed, and processed in Synapse Commons Repository (https:// synapse.sagebase.org/). With the exception of the Hunter et al. study (8) (GSE8881), we implemented the default one-color Affymetrix and default two-color Agilent workflows for each dataset. The former removes intensitydependent array effects, and the latter removes both intensity-dependent array and dye effects. A single study, the Elf1 dataset, required a more sophisticated model, which in this case meant correcting for the effects of an outlier sample. Further methods are defined in Supporting Information.
Immunohistochemistry. Triple immunofluorescent labeling to detect endoderm in teratoma sections was performed as previously published with minor modifications (26) . Methods are further defined in Supporting Information.
Further methods for array analysis, immunohistochemistry, flow cytometry, quantitative PCR, XIST FISH, bisulfite sequencing, teratoma formation, karyotype analysis, and electron microscopy can be found in Supporting Information.
